Neurology Central

Multiple sclerosis: new UK guidelines on disease-modifying therapies

0
The UK National Institute for Health and Care Excellence (NICE) has issued its Final Appraisal Determination recommending the use of four out of six disease-modifying therapies (DMTs) in relapsing–remitting multiple sclerosis (RRMS).
To view restricted content, please:
Share:

Leave A Comment